Tony Coles, Yumanity chairman and co-founder
Tony Coles takes second neuroscience startup public as Yumanity reverse merges
Maybe Tony Coles just doesn’t like IPOs.
A month after taking one of his two neuroscience biotechs — Cerevel — public as part of a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
